Jul 9, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
Merck To Initiate Proof-Of-Concept Study Of Posaconazole For Chronic Chagas Disease
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2214427" data-attributes="member: 124445"><p>Merck announced plans to initiate a Phase II investigational proof-of-concept clinical study to evaluate its oral antifungal agent posaconazole for the treatment of chronic Chagas disease. Chagas disease results from infection with the parasite Trypanosoma cruzi that is spread by biting insects. The disease is estimated to affect approximately eight million people in Latin America, of whom approximately 30-40 percent will develop serious cardiac disease, digestive disease, or both as a result of this infection... <a href="http://feedads.g.doubleclick.net/~a/pCxYKFdCG_fvxU5BIc4lOfCc9ls/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/pCxYKFdCG_fvxU5BIc4lOfCc9ls/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/pCxYKFdCG_fvxU5BIc4lOfCc9ls/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/pCxYKFdCG_fvxU5BIc4lOfCc9ls/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/3i_rmnslE40" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/3i_rmnslE40/3FqX" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2214427, member: 124445"] Merck announced plans to initiate a Phase II investigational proof-of-concept clinical study to evaluate its oral antifungal agent posaconazole for the treatment of chronic Chagas disease. Chagas disease results from infection with the parasite Trypanosoma cruzi that is spread by biting insects. The disease is estimated to affect approximately eight million people in Latin America, of whom approximately 30-40 percent will develop serious cardiac disease, digestive disease, or both as a result of this infection... [URL="http://feedads.g.doubleclick.net/~a/pCxYKFdCG_fvxU5BIc4lOfCc9ls/0/da"][IMG]http://feedads.g.doubleclick.net/~a/pCxYKFdCG_fvxU5BIc4lOfCc9ls/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/pCxYKFdCG_fvxU5BIc4lOfCc9ls/1/da"][IMG]http://feedads.g.doubleclick.net/~a/pCxYKFdCG_fvxU5BIc4lOfCc9ls/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/3i_rmnslE40[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/3i_rmnslE40/3FqX]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top